Fox Chase Cancer Center and Martinique Cancer Registry to Host African-Caribbean Cancer Consortium’s Fifth Conference
The International Conference of the African-Caribbean Cancer Consortium—hosted by Fox Chase Cancer Center in Philadelphia and the Martinique Cancer Registry—will bring more than 100 researchers from around the world to Schoelcher, Martinique, in the French Caribbean on October 9 through 11, 2014, to share findings and progress regarding cancer health concerns in underserved minority populations. Members of the public are encouraged to attend the first day of the conference, which will include programming geared toward the community.
Founded by Camille Ragin, PhD, MPH, an Associate Professor at Fox Chase who specializes in the study of cancer risk and poor outcomes in minority populations, the African-Caribbean Cancer Consortium (AC3) is a multi-institutional collaborative body that focuses on studies of cancer risk and outcomes among populations of African ancestry, including African-American, African, and Caribbean. The 48 member institutions involved in AC3 represent 17 U.S. states and 17 countries in the Caribbean and Africa.
The first day of the conference will give members of the public the opportunity to interact directly with researchers as they participate in lay-friendly cancer prevention workshops such as “Healthy Lifestyles: Reducing Cancer Risk” and “Cancer Screening, Risk and Survivorship”.
The second day of the conference will feature presentations of research projects and findings by registered AC3 members. There will be sessions on various cancers, including hematologic malignancies, cancer staging, gene-environment interactions, training workshop on genomics, CBPR, and cancer registration and more.
To learn more about the International Conference of the African-Caribbean Cancer Consortium and AC3, visit www.ac3online.org.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet status for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. (PR)
